AKT1 and diffuse large B-cell lymphoma: Mir-17-92 targets and negatively regulates expression of PTEN protein, therefore, mir-17-92 amplification, which occurs exclusively in GCB DLBCL (~8%) (16), leads to PI3K/AKT activation.